TY - JOUR
TI - Zanubrutinib for mantle cell lymphoma, Waldenström’s macroglobulinaemia
J2 - Aust Prescr
JF - Australian Prescriber
PY - 2022
ET - 2021/12/10
VL - 45
IS - 1
SP - 34
EP - 35
DO - 10.18773/austprescr.2021.066
LA - eng
UR - https://australianprescriber.tg.org.au/articles/zanubrutinib-for-mantle-cell-lymphoma-waldenstroms-macroglobulinaemia.html
KW - Brukinsa
KW - mantle cell lymphoma
KW - Waldenström’s macroglobulinaemia
KW - zanubrutinib
PB - Therapeutic Guidelines Ltd
SN - 1839-3942
ER -